Precision Nutrition Recommendations Generated by Metataxonomic Microbiome Testing Improve Food Group Choices and Intestinal Health Indicators in an Obese Population in Colombia
1 other identifier
interventional
50
1 country
1
Brief Summary
This study evaluated whether personalized dietary recommendations based on gut microbiome testing can improve intestinal health and food choices in adults with obesity in the region of Antioquia, Colombia. Fifty participants were randomly assigned to an intervention or control group. Outcomes included gut microbiome composition, blood biomarkers, weight, physical activity frequency, and dietary adherence over 12 weeks
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2024
CompletedFirst Submitted
Initial submission to the registry
March 12, 2026
CompletedFirst Posted
Study publicly available on registry
March 25, 2026
CompletedMarch 25, 2026
July 1, 2023
8 months
March 12, 2026
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in gut microbiota diversity (Shannon Index)
Change in gut microbiota diversity assessed using the Shannon Diversity Index via 16S rRNA sequencing (V3-V4 region).
Baseline and up to 3 months
Secondary Outcomes (9)
Change in glycated hemoglobin (HbA1c)
Baseline and up to 3 months
Change in HDL cholesterol
Baseline and up to 12 weeks
Change in LDL cholesterol
Baseline and 12 weeks
Change in triglycerides
Baseline and 12 weeks
Change in total cholesterol
Baseline and 12 weeks
- +4 more secondary outcomes
Study Arms (2)
Control Group
NO INTERVENTIONExperimental Group
EXPERIMENTALInterventions
Experimental: Personalized dietary intervention (n=25) Participants receive personalized dietary recommendations intended to improve gut microbiota diversity and metabolic health. Recommendations include increased dietary fiber intake, incorporation of fermented foods, reduced intake of added sugars and saturated fats, and increased consumption and variety of fruits and vegetables. Optional probiotic or prebiotic supplementation may be recommended. Adherence is monitored through periodic online questionnaires and regular phone or text message follow-ups. Precise nutrient intake and supplement dosages are not strictly quantified. Behavioral: Personalized dietary recommendations Individualized dietary guidance designed to promote gut microbiota diversity and metabolic health through increased fiber intake, fermented foods, reduced added sugars and saturated fats, and greater variety of fruits and vegetables. Optional probiotic or prebiotic supplementation may be included.
Eligibility Criteria
You may qualify if:
- Affiliation with Comfama healthcare provider
- Age between 23 and 65 years
- Body Mass Index (BMI) ≥ 30 kg/m²
- Residence in Medellín, Antioquia, Colombia
- Willingness and ability to participate in the study for 12 weeks
You may not qualify if:
- Pregnancy or lactation
- History of bariatric surgery
- Diagnosed mental health conditions
- Use of specific medications (e.g., antidepressants, antibiotics)
- Participation in a structured nutritional plan
- Planned extended travel within the next 9 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Astrolab biolead
- EPS COMFAMAcollaborator
Study Sites (1)
Astrolab-bio
Medellín, Antioquia, 050022, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2026
First Posted
March 25, 2026
Study Start
July 10, 2023
Primary Completion
February 20, 2024
Study Completion
February 20, 2024
Last Updated
March 25, 2026
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Beginning 1 year after publication with no end date
- Access Criteria
- The data will only be shared by demand with other researchers that belong to recognized institutions according to the ORCID affiliation. All data sharing will be anonymous.
We will only share this information by demand of the journal were the study will be published or with other researchers from recognized institutions (according to their ORCID profile) that direclty ask for the data. All data will be anonymous.